| Tyneishia Cunningham King, | |
|
1207 E Forrest St Ste 204d, Athens, AL 35613-2057 | |
| (256) 230-5280 | |
| (256) 427-4117 |
| Full Name | Tyneishia Cunningham King |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 1207 E Forrest St Ste 204d, Athens, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235788415 | NPI | - | NPPES |
| 009937074 | Medicaid | AL |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Empower2, Llc | 6103185145 | 14 |
News Archive
Prof. TIAN Chao's group from the Department of Precision Machinery and Instrumentation, University of Science and Technology of China of the Chinese Academy of Sciences has made progress on the photoacoustic imaging for medical science.
Researchers at the University of Alabama at Birmingham have shed new light on how cells called gliomas migrate in the brain and cause devastating tumors.
Stand Up To Cancer announced here today the creation of an $8 million Dream Team of top scientists focused on finding therapies for T-cell lymphoma, a rare cancer of the blood and immune system, using chimeric antigen receptors (CARs) to trigger the immune system to attack and destroy cancerous cells.
A new study on the surface chemistry of silver-colored, mercury-based dental fillings suggests that the surface forms of mercury may be less toxic than previously thought. It appears online in ACS' journal Chemical Research in Toxicology.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
› Verified 8 days ago
| Entity Name | Empower2, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669985503 PECOS PAC ID: 6103185145 Enrollment ID: O20180119000244 |
News Archive
Prof. TIAN Chao's group from the Department of Precision Machinery and Instrumentation, University of Science and Technology of China of the Chinese Academy of Sciences has made progress on the photoacoustic imaging for medical science.
Researchers at the University of Alabama at Birmingham have shed new light on how cells called gliomas migrate in the brain and cause devastating tumors.
Stand Up To Cancer announced here today the creation of an $8 million Dream Team of top scientists focused on finding therapies for T-cell lymphoma, a rare cancer of the blood and immune system, using chimeric antigen receptors (CARs) to trigger the immune system to attack and destroy cancerous cells.
A new study on the surface chemistry of silver-colored, mercury-based dental fillings suggests that the surface forms of mercury may be less toxic than previously thought. It appears online in ACS' journal Chemical Research in Toxicology.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
› Verified 8 days ago
| Entity Name | Aderholt Medical Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164023529 PECOS PAC ID: 3577972611 Enrollment ID: O20210503000414 |
News Archive
Prof. TIAN Chao's group from the Department of Precision Machinery and Instrumentation, University of Science and Technology of China of the Chinese Academy of Sciences has made progress on the photoacoustic imaging for medical science.
Researchers at the University of Alabama at Birmingham have shed new light on how cells called gliomas migrate in the brain and cause devastating tumors.
Stand Up To Cancer announced here today the creation of an $8 million Dream Team of top scientists focused on finding therapies for T-cell lymphoma, a rare cancer of the blood and immune system, using chimeric antigen receptors (CARs) to trigger the immune system to attack and destroy cancerous cells.
A new study on the surface chemistry of silver-colored, mercury-based dental fillings suggests that the surface forms of mercury may be less toxic than previously thought. It appears online in ACS' journal Chemical Research in Toxicology.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tyneishia Cunningham King, 1207 E Forrest St Ste 204d, Athens, AL 35613-2057 Ph: (256) 301-5405 | Tyneishia Cunningham King, 1207 E Forrest St Ste 204d, Athens, AL 35613-2057 Ph: (256) 230-5280 |
News Archive
Prof. TIAN Chao's group from the Department of Precision Machinery and Instrumentation, University of Science and Technology of China of the Chinese Academy of Sciences has made progress on the photoacoustic imaging for medical science.
Researchers at the University of Alabama at Birmingham have shed new light on how cells called gliomas migrate in the brain and cause devastating tumors.
Stand Up To Cancer announced here today the creation of an $8 million Dream Team of top scientists focused on finding therapies for T-cell lymphoma, a rare cancer of the blood and immune system, using chimeric antigen receptors (CARs) to trigger the immune system to attack and destroy cancerous cells.
A new study on the surface chemistry of silver-colored, mercury-based dental fillings suggests that the surface forms of mercury may be less toxic than previously thought. It appears online in ACS' journal Chemical Research in Toxicology.
A Novartis Pharmaceuticals Corporation Phase III study of Afinitor® (everolimus) tablets in combination with Sandostatin® LAR Depot (octreotide acetate for injectable suspension) extended median progression-free survival (PFS), or time without tumor growth, in patients with advanced carcinoid tumors compared to taking octreotide LAR alone.
› Verified 8 days ago
Zachary Andrew Curtis, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 700 W Market St, Athens, AL 35611 Phone: 256-233-9292 | |
Marla Renee Mcclure, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 12100 Two Rivers Dr Apt J-1, Athens, AL 35611 Phone: 564-600-2472 | |
Anne Tate Wilson, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 101 Fitness Way, Suite 1200, Athens, AL 35611 Phone: 256-232-0636 Fax: 256-232-1281 | |
Lindsay Traynom, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 22454 Us Highway 72 Ste 200, Athens, AL 35613 Phone: 256-233-2332 | |
Diane Goodman Waits, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 700 W Market St, Athens, AL 35611 Phone: 800-893-9698 | |
April Seay, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7715 Us Highway 72, Athens, AL 35611 Phone: 256-729-9477 | |
Christina C Vail, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 700 W Market St, Athens, AL 35611 Phone: 256-233-9292 |